283 related articles for article (PubMed ID: 32589943)
1. PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression.
Kudo Y; Sugimoto M; Arias E; Kasashima H; Cordes T; Linares JF; Duran A; Nakanishi Y; Nakanishi N; L'Hermitte A; Campos A; Senni N; Rooslid T; Roberts LR; Cuervo AM; Metallo CM; Karin M; Diaz-Meco MT; Moscat J
Cancer Cell; 2020 Aug; 38(2):247-262.e11. PubMed ID: 32589943
[TBL] [Abstract][Full Text] [Related]
2. PKCλ/ι Loss Induces Metabolic Reprogramming in Liver Cancer: Hitting Two Birds with One Stone?
Ramadori P; Li X; Heikenwalder M
Cancer Cell; 2020 Aug; 38(2):152-154. PubMed ID: 32781040
[TBL] [Abstract][Full Text] [Related]
3. The interplay between PRKCI/PKCλ/ι, SQSTM1/p62, and autophagy orchestrates the oxidative metabolic response that drives liver cancer.
Moscat J; Diaz-Meco MT
Autophagy; 2020 Oct; 16(10):1915-1917. PubMed ID: 32686580
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression.
Ma-On C; Sanpavat A; Whongsiri P; Suwannasin S; Hirankarn N; Tangkijvanich P; Boonla C
Med Oncol; 2017 Apr; 34(4):57. PubMed ID: 28281193
[TBL] [Abstract][Full Text] [Related]
5. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in autophagy-induced hepatocellular carcinoma.
Zhou J; Zhang X; Tang H; Yu J; Zu X; Xie Z; Yang X; Hu J; Tan F; Li Q; Lei X
Clin Chim Acta; 2020 Jul; 506():1-8. PubMed ID: 32109431
[TBL] [Abstract][Full Text] [Related]
7. PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesis.
Linares JF; Zhang X; Martinez-Ordoñez A; Duran A; Kinoshita H; Kasashima H; Nakanishi N; Nakanishi Y; Carelli R; Cappelli L; Arias E; Yashiro M; Ohira M; Patel S; Inghirami G; Loda M; Cuervo AM; Diaz-Meco MT; Moscat J
Mol Cell; 2021 Nov; 81(21):4509-4526.e10. PubMed ID: 34560002
[TBL] [Abstract][Full Text] [Related]
8. Def-6, a novel regulator of small GTPases in podocytes, acts downstream of atypical protein kinase C (aPKC) λ/ι.
Worthmann K; Leitges M; Teng B; Sestu M; Tossidou I; Samson T; Haller H; Huber TB; Schiffer M
Am J Pathol; 2013 Dec; 183(6):1945-1959. PubMed ID: 24096077
[TBL] [Abstract][Full Text] [Related]
9. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
Kowalik MA; Guzzo G; Morandi A; Perra A; Menegon S; Masgras I; Trevisan E; Angioni MM; Fornari F; Quagliata L; Ledda-Columbano GM; Gramantieri L; Terracciano L; Giordano S; Chiarugi P; Rasola A; Columbano A
Oncotarget; 2016 May; 7(22):32375-93. PubMed ID: 27070090
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase Cλ/ι in cancer: a contextual balance of time and signals.
Moscat J; Linares JF; Duran A; Diaz-Meco MT
Trends Cell Biol; 2022 Dec; 32(12):1023-1034. PubMed ID: 35501226
[TBL] [Abstract][Full Text] [Related]
11. Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesis.
Han B; Shin HJ; Bak IS; Bak Y; Jeong YL; Kwon T; Park YH; Sun HN; Kim CH; Yu DY
Oncotarget; 2016 Oct; 7(42):68044-68056. PubMed ID: 27517622
[TBL] [Abstract][Full Text] [Related]
12. NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis.
Guo H; Xu J; Zheng Q; He J; Zhou W; Wang K; Huang X; Fan Q; Ma J; Cheng J; Mei W; Xing R; Cai R
Cancer Lett; 2019 Dec; 466():39-48. PubMed ID: 31546024
[TBL] [Abstract][Full Text] [Related]
13. CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
Wang S; Cao K; Liao Y; Zhang W; Zheng J; Li X; Huang M; Zhong Y; Hu X; Chen D; Wang Y
Oncogene; 2021 Jun; 40(25):4368-4383. PubMed ID: 34103686
[TBL] [Abstract][Full Text] [Related]
14. Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line.
Maurya AK; Vinayak M
Mol Biol Rep; 2015 Sep; 42(9):1419-29. PubMed ID: 26311153
[TBL] [Abstract][Full Text] [Related]
15. Expression of P-aPKC-iota, E-cadherin, and beta-catenin related to invasion and metastasis in hepatocellular carcinoma.
Du GS; Wang JM; Lu JX; Li Q; Ma CQ; Du JT; Zou SQ
Ann Surg Oncol; 2009 Jun; 16(6):1578-86. PubMed ID: 19290490
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma.
Zhang M; Zhang C; Zhang L; Yang Q; Zhou S; Wen Q; Wang J
BMC Cancer; 2015 Jul; 15():531. PubMed ID: 26194347
[TBL] [Abstract][Full Text] [Related]
17. Significance and expression of atypical protein kinase C-iota in human hepatocellular carcinoma.
Wang JM; Li Q; Du GS; Lu JX; Zou SQ
J Surg Res; 2009 Jun; 154(1):143-9. PubMed ID: 19101699
[TBL] [Abstract][Full Text] [Related]
18. NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines.
Haque E; Śmiech M; Łuczyńska K; Bouchard MF; Viger R; Kono H; Pierzchała M; Taniguchi H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069882
[TBL] [Abstract][Full Text] [Related]
19. FGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4-GSK3β-Nrf2 Signaling.
Teng Y; Zhao H; Gao L; Zhang W; Shull AY; Shay C
Cancer Res; 2017 Nov; 77(22):6215-6225. PubMed ID: 28951455
[TBL] [Abstract][Full Text] [Related]
20. Autophagy inhibits oxidative stress and tumor suppressors to exert its dual effect on hepatocarcinogenesis.
Tian Y; Kuo CF; Sir D; Wang L; Govindarajan S; Petrovic LM; Ou JH
Cell Death Differ; 2015 Jun; 22(6):1025-34. PubMed ID: 25526090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
